Endometriosis - Intima, Reckitt | Clapboard Ad Archive

Intima and Reckitt’s Endometriosis campaign, developed with BETC and released in France in 2021, stands as a case study in contemporary narrative-driven health communication, leveraging the sensitivities of the women’s health category with a strategy focused squarely on destigmatizing a chronically misunderstood condition. The creative proposition is direct and empathetic: to position Intima not simply as a provider of intimate care products but as an informed ally advocating for women contending with the daily realities of endometriosis, a chronic illness historically neglected in both public discourse and advertising. The campaign’s foundation rests on a structured, story-led approach—what Clapboard’s taxonomy would classify as FORMAT#2—Show the Problem—moving beyond abstract awareness to vividly depict the lived struggles associated with the condition before introducing Intima’s solution-oriented point of view, a technique that privileges relatability and authenticity over didactic messaging. BETC’s execution resists the urge to sensationalize or rely on testimonial conventions; instead, it spotlights the emotional and physical tolls faced by sufferers, aligning the narrative closely with the medical and social context within which Intima operates and reinforcing Reckitt’s commitment to health and wellbeing. The selection of film as the medium amplifies the campaign’s intent, using cinematic language to foster empathy and validation among its target—primarily women grappling with symptoms who are underserved by mainstream communications. In a market where larger healthcare brands like Johnson & Johnson, Bayer Healthcare, and Sanofi compete on platforms of innovation, reliability, and scientific authority, Intima’s project asserts a distinctive stance by making visibility and support its central currency, subtly yet deliberately differentiating itself through education and social advocacy rather than hardware or clinical claims. While the campaign favors a narrowcast over a broadcast approach, prioritizing quality of connection over sheer reach, it is precisely this intent that marks its value in the broader health industry landscape. The campaign earns 63/100 in Clapboard's global creative archive. In foregrounding the patient’s experience and sidestepping the product push, this campaign signals a maturing of health category communications, where brands are compelled to compete not only on medical efficacy but on their willingness to understand, validate, and elevate lived realities that have long been overlooked.